Karl Weiss, C. Restieri, Michel Laverdière, Allison McGeer, Ross J. Davidson, Laurie Kilburn, Darrin J. Bast, Joyce de Azavedo, Carla Duncan, and Donald E. Low. Treatment failure and progression of resistance in an outbreak of nosocomial Streptococcus pneumoniae respiratory infections. Submitted, 2000 NEJM.

Andrew M. Morris, Shelley Deeks, Michael Hill, Gyl Midroni, Warren Goldstein, Tony Mazzulli, Ross Davidson, Susan Squires, Tom Marrie, Allison McGeer, and Donald E. Low, for the Bell's Palsy Study Group. A Pseudo-outbreak of Bell's palsy in the Greater Toronto Area. Submitted, 2000 NEJM.

Darrin Bast, Donald E. Low, Carla Duncan, Laurie Kilburn, Ross Davidson, Lionel Mandell. Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae: Contributions of Type II Topoisomerase Mutations and Efflux on Levels of Resistance. Submitted, 2000 J. Infect. Dis.

Davidson RJ, Canadian Bacterial Surveillance Network, and Low DE. A Cross Canada Surveillance of Antimicrobial Resistance in Respiratory Tract Pathogens: 1999. Canadian Journal of Infectious Diseases. Can. J. Infect. Dis. 1999. 10:128-133.

Low DE, de Azavedo J, Canadian Bacterial Surveillance Network, Davidson RJ. In-Vitro Activity of Cefepime against Multidrug Resistant Gram Negative Bacilli and Gram Positive Cocci: Results of a Cross-Canada Surveillance Study. Can. J. Infect. Dis. 1999. 10:122-127

Davidson Ross J and Low Donald E. Staphylococcus epidermidis and Other Coagulase Negative Staphylococci. In: Antimicrobial Chemotherapy. Yu VL, Merigan TC, Barriere S (eds). 1998 Williams and Wilkins, Baltimore.

Abstracts

Davidson RJ, Fuller J, Mazzuli T, Porter-Pong S, McGeer A, and Low D.E. High-Level Trimethoprim-sulfamethoxazole (TMP/SMX) Resistance in Community Acquired Urinary Tract Gram Negative Isolates. 1998. ASM's 38^th ICAAC. San Diego.

Davidson RJ, Fuller J, and Low D.E. Pharmacodynamic Properties of Moxifloxacin, Levofloxacin and Clarithromycin in S.pneumoniae and H.influenzae. 1998. ASM's 38^th ICAAC. San Diego.

Davidson RJ, McGeer, A, Porter-Pong S, and Low DE. Marked Variability of beta-lactam Resistance in H.influenzae from Nine Geographically Distinct Countries. 1998. ASM's 38^th ICAAC. San Diego.

Davidson RJ, Fuller J, and Low DE. Postantibiotic Effect of Trovafloxacin in S.pneumoniae and Viridans Streptococci with Diminished Susceptibility to Ciprofloxacin. 1998. 6^th International Symposium on Quinolones. Denver, Colorado

Davidson RJ, MacKenzie H, Forward K, deAzavedo J, Duncan K, Bast D, McGeer A, Mandell L, Weiss K and Low DE. Comparative Activity of New Generation Fluoroquinolones Against S.pneumoniae with Documented Topoisomerase IV (parC) and DNA Gyrase (gyrA) mutations. 1999 ASM's 39^th ICAAC. San Francisco

Weiss K, Restieri C, Laverdiere M, Davidson RJ, McGeer A, de Azavedo J, and Low DE. A Nosocomial Outbreak of Streptococcus pneumoniae (Sp) with Reduced Susceptibility to Fluoroquinolones. 1999. ASM's 39^th ICAAC. San Francisco

Duncan CL, Bast DJ, Kilburn L, MacKenzie H, Davidson R, Mandell L, Low DE , de Azavedo JCS. Type II Topoisomerase Mutations Associated with Fluoroquinolone (FQ) Resistance in Clinical Isolates of Streptococcus pneumoniae (SPN). 1999. ASM's 39^th ICAAC. San Francisco

Davidson RJ, MacKenzie H, Forward K, deAzavedo J, Duncan K, Bast D, McGeer A, Mandell L, Weiss K and Low DE. Gemifloxacin (SB-265805) is Active Against S.pneumoniae with Documented Topoisomerase IV (parC) and DNA Gyrase (gyrA) mutations. 1999. ACCP, Portofino, Italy

Arbique J, K. Forward, D. Haldane, R. Davidson. Erythromycin and Clindamycin Resistance in Pharyngeal Isolates of Group A Streptococcus (GAS) in Halifax. 1999 CACMID, Edmonton, Alberta

Jane Gillis, Todd Hatchette, Heather MacKenzie, Tom Marrie, and Ross Davidson. A Novel Method for the Detection of Coxiella burnetii in Goat's Milk using Human Anti-Coxiella Sensitized Immuno-Magnetic Beads and PCR. 2000. 100^th SM General Meeting. Los Angeles, CA